News

Healthline20h
First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
Medical News Today21h
Diabetes and weight loss drug semaglutide may also treat liver disease
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
pharmaphorum19h
Digital support reduces GLP-1 dose needed for weight loss
Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...
Rolling Out19h
Weight-loss injections slash cancer risk
Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...
GLP-1 drugs made a former FDA chief ‘feel ill.’ But he’d take them again.
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...
ConsumerAffairs15h
What is the strongest weight loss prescription pill?
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.